Physician profile
Robert Alpern
NPI 1477785285
$4,881,772.78
in general payments reported to CMS, 2019-2025
2 companies · $757K in 2025
The $757K reported for 2025 was more than what 99% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $580K · 2020: $561K · 2021: $698K · 2022: $851K · 2023: $672K · 2024: $763K · 2025: $757K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $901K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $750K · Travel and Lodging: $398K · Charitable Contribution: $75K · Food and Beverage: $67K · Gift: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $900,728.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $750,376.20 |
| Travel and Lodging | $397,561.83 |
| Charitable Contribution | $75,000.00 |
| Food and Beverage | $66,981.16 |
| Gift | $1,345.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,803,423.53 | 2019-2025 | |
| Abbvie INC. | $2,078,349.25 | 2019-2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Alpern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.